Comparison of Percutaneous Renal Mass Biopsy and R.E.N.A.L. Nephrometry Score Nomograms for Determining Benign Vs Malignant Disease and Low-risk Vs High-risk Renal Tumors.

MLA

Osawa, Takahiro, et al. “Comparison of Percutaneous Renal Mass Biopsy and R.E.N.A.L. Nephrometry Score Nomograms for Determining Benign Vs Malignant Disease and Low-Risk Vs High-Risk Renal Tumors.” Urology, vol. 96, Oct. 2016, pp. 87–92. EBSCOhost, https://doi.org/10.1016/j.urology.2016.05.044.

APA

Osawa, T., Hafez, K. S., Miller, D. C., Montgomery, J. S., Morgan, T. M., Palapattu, G. S., Weizer, A. Z., Caoili, E. M., Ellis, J. H., Kunju, L. P., & Wolf, J. S., Jr. (2016). Comparison of Percutaneous Renal Mass Biopsy and R.E.N.A.L. Nephrometry Score Nomograms for Determining Benign Vs Malignant Disease and Low-risk Vs High-risk Renal Tumors. Urology, 96, 87–92. https://doi.org/10.1016/j.urology.2016.05.044

Chicago

Osawa, Takahiro, Khaled S Hafez, David C Miller, Jeffrey S Montgomery, Todd M Morgan, Ganesh S Palapattu, Alon Z Weizer, et al. 2016. “Comparison of Percutaneous Renal Mass Biopsy and R.E.N.A.L. Nephrometry Score Nomograms for Determining Benign Vs Malignant Disease and Low-Risk Vs High-Risk Renal Tumors.” Urology 96 (October): 87–92. doi:10.1016/j.urology.2016.05.044.